These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6607482)

  • 21. Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense.
    Messaoudi I; Guevara Patiño JA; Dyall R; LeMaoult J; Nikolich-Zugich J
    Science; 2002 Nov; 298(5599):1797-800. PubMed ID: 12459592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Migratory dendritic cells: sometimes simply ferries?
    Randolph GJ
    Immunity; 2006 Jul; 25(1):15-8. PubMed ID: 16860753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytotoxic T lymphocyte activity after intravitreal inoculation of herpes simplex virus type I in mice].
    Tsumura K
    Nippon Ganka Gakkai Zasshi; 1993 Jul; 97(7):820-6. PubMed ID: 8352079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions.
    Ksander BR; Hendricks RL
    Invest Ophthalmol Vis Sci; 1987 Dec; 28(12):1986-93. PubMed ID: 2824400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-1) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge.
    Banks TA; Jenkins FJ; Kanangat S; Nair S; Dasgupta S; Foster CM; Rouse BT
    Virology; 1994 Apr; 200(1):236-45. PubMed ID: 8128625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice.
    Hendricks RL; Tumpey TM; Finnegan A
    J Immunol; 1992 Nov; 149(9):3023-8. PubMed ID: 1401927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine.
    Jamali A; Mahdavi M; Hassan ZM; Sabahi F; Farsani MJ; Bamdad T; Soleimanjahi H; Motazakker M; Shahabi S
    Int Immunol; 2009 Mar; 21(3):217-25. PubMed ID: 19174474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD; Butler LD
    J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
    Paya CV; McKean DJ; Segal DM; Schoon RA; Showalter SD; Leibson PJ
    J Immunol; 1989 Jan; 142(2):666-71. PubMed ID: 2536060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmentation of immunity to herpes simplex virus by in vivo administration of interleukin 2.
    Rouse BT; Miller LS; Turtinen L; Moore RN
    J Immunol; 1985 Feb; 134(2):926-30. PubMed ID: 2981270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
    McNally JM; Dempsey D; Wolcott RM; Chervenak R; Jennings SR
    J Immunol; 1999 Jul; 163(2):675-81. PubMed ID: 10395657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of delayed-type hypersensitivity. VI. Antigen-specific suppressor T cells and suppressor factor for delayed-type hypersensitivity to histocompatibility antigens.
    Liew FY
    Transplantation; 1982 Jan; 33(1):69-76. PubMed ID: 6461112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-mediated immune response to herpes simplex virus: type-specific lymphoproliferative responses in lymph nodes draining the site of primary infection.
    Jacobs RP; Aurelian L; Cole GA
    J Immunol; 1976 Jun; 116(6):1520-5. PubMed ID: 58037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection.
    Martin S; Rouse BT
    J Immunol; 1987 May; 138(10):3431-7. PubMed ID: 3033075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
    Milligan GN; Bernstein DI
    Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming.
    Allan RS; Waithman J; Bedoui S; Jones CM; Villadangos JA; Zhan Y; Lew AM; Shortman K; Heath WR; Carbone FR
    Immunity; 2006 Jul; 25(1):153-62. PubMed ID: 16860764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes.
    Pfizenmaier K; Jung H; Starzinski-Powitz A; Röllinghoff M; Wagner H
    J Immunol; 1977 Sep; 119(3):939-44. PubMed ID: 70478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of stress on memory cytotoxic T lymphocyte-mediated protection against herpes simplex virus infection at mucosal sites.
    Wonnacott KM; Bonneau RH
    Brain Behav Immun; 2002 Apr; 16(2):104-17. PubMed ID: 11908921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.